PCSC
Freenome, Inc.
Key Financials
Net Income
$837468
↓ 56.2%
Operating Income
$-2980553
↓ 503.3%
Total Liabilities
$5.7M
↑ 55.8%
Total Assets
$92.8M
↑ 3.2%
Operating Cash Flow
$-864653.00
↓ 144.5%
Shareholders' Equity
$-4796674.00
↓ 126.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 9/23/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| SCHEDULE 13G | 9/1/2026 | View on SEC |
| EFFECT | 8/27/2026 | View on SEC |
| 424B3 | 8/27/2026 | View on SEC |
| S-1 | 8/18/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| 8-K/A | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PCSC |
| Company Name | Freenome, Inc. |
| CIK | 2017526 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 212-284-2300 |